| Patent | Date |
|---|
Use Of Ave0010 For The Manufacture Of A Medicament For The Treatment Of Diabetes Mellitus Type 2
App 20220054594 - Boka; Gabor ; et al. | 2022-02-24 |
Insulin Glargine/lixisenatide Fixed Ratio Formulation
App 20220031811 - Souhami; Elisabeth ; et al. | 2022-02-03 |
Insulin glargine/lixisenatide fixed ratio formulation
Grant 11,026,999 - Souhami , et al. June 8, 2 | 2021-06-08 |
Insulin Glargine/lixisenatide Fixed Ratio Formulation
App 20210128692 - Souhami; Elisabeth ; et al. | 2021-05-06 |
Use Of Ave0010 For The Treatment Of Diabetes Mellitus Type 2
App 20200353054 - Boka; Gabor ; et al. | 2020-11-12 |
Pharmaceutical Combination For Improving Glycemic Control As Add-on Therapy To Basal Insulin
App 20200338171 - NIEMOELLER; Elisabeth ; et al. | 2020-10-29 |
Pharmaceutical Combination For Use In Glycemic Control In Diabetes Type 2 Patients
App 20200330559 - Niemoeller; Elisabeth ; et al. | 2020-10-22 |
Insulin Glargine/lixisenatide Fixed Ratio Formulation
App 20200038488 - Souhami; Elisabeth ; et al. | 2020-02-06 |
Insulin Glargine/lixisenatide Fixed Ratio Formulation
App 20190381145 - Souhami; Elisabeth ; et al. | 2019-12-19 |
Pharmaceutical Combination for Use in Glycemic Control in Diabetes Type 2 Patients
App 20190134160 - Niemoeller; Elisabeth ; et al. | 2019-05-09 |
Insulin Glargine/Lixisenatide Fixed Ratio Formulation
App 20190060411 - Souhami; Elisabeth ; et al. | 2019-02-28 |
Prevention Of Hypoglycemia In Diabetes Mellitus Type 2 Patients
App 20190054146 - Silvestre; Louise ; et al. | 2019-02-21 |
Use of AVE0010 for the Treatment of Diabetes Mellitus Type 2
App 20190030132 - Boka; Gabor ; et al. | 2019-01-31 |
Pharmaceutical Combination For Improving Glycemic Control As Add-on Therapy To Basal Insulin
App 20180339023 - NIEMOELLER; Elisabeth ; et al. | 2018-11-29 |
Use of AVE0010 for the treatment of diabetes mellitus type 2
Grant 9,981,013 - Boka , et al. May 29, 2 | 2018-05-29 |
Insulin glargine/lixisenatide fixed ratio formulation
App 20180133290 - Souhami; Elisabeth ; et al. | 2018-05-17 |
Insulin glargine/lixisenatide fixed ratio formulation
Grant 9,950,039 - Souhami , et al. April 24, 2 | 2018-04-24 |
Prevention Of Hypoglycaemia In Diabetes Mellitus Type 2 Patients
App 20180000902 - Boka; Gabor ; et al. | 2018-01-04 |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
Grant 9,821,032 - Niemoeller , et al. November 21, 2 | 2017-11-21 |
Pharmaceutical Combination for Use in Glycemic Control in Diabetes Type 2 Patients
App 20170143801 - NIEMOELLER; Elisabeth ; et al. | 2017-05-25 |
Method Of Treatment Of Diabetes Type 2 Comprising Add-on Therapy To Insulin Glargine And Metformin
App 20170136094 - SILVESTRE; Louise ; et al. | 2017-05-18 |
Use Of Ave0010 For The Treatment Of Diabetes Mellitus Type 2
App 20170119852 - BOKA; Gabor ; et al. | 2017-05-04 |
Prevention Of Hypoglycemia In Diabetes Mellitus Type 2 Patients
App 20170080057 - SILVESTRE; Louise ; et al. | 2017-03-23 |
Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
Grant 9,408,893 - Niemoeller , et al. August 9, 2 | 2016-08-09 |
Insulin glargine/lixisenatide fixed ratio formulation
App 20160199452 - Souhami; Elisabeth ; et al. | 2016-07-14 |
Insulin glargine/lixisenatide fixed ratio formulation
App 20140371141 - Souhami; Elisabeth ; et al. | 2014-12-18 |
Use Of Ave0010 For The Manufacture Of A Medicament For The Treatment Of Diabetes Mellitus Type 2
App 20140148384 - Boka; Gabor ; et al. | 2014-05-29 |
Method for improving glucose tolerance in a diabetes type 2 patient of younger than 50 years and having postprandial plasma glucose concentration of at least 14 mmol/L
Grant 8,735,349 - Silvestre , et al. May 27, 2 | 2014-05-27 |
Treatment Protocol Of Diabetes Type 2
App 20130296236 - SILVESTRE; Louise ; et al. | 2013-11-07 |
Pharmaceutical Combination For Use In Glycemic Control In Diabetes Type 2 Patients
App 20130203666 - NIEMOELLER; Elisabeth ; et al. | 2013-08-08 |
Prevention Of Hypoglycemia In Diabetes Mellitus Type 2 Patients
App 20130085102 - SILVESTRE; Louise ; et al. | 2013-04-04 |
Pharmaceutical Combination For Use In Glycemic Control In Diabetes Type 2 Patients
App 20130065828 - RUUS; Peter ; et al. | 2013-03-14 |
Pharmaceutical Combination For Use In The Treatment Of Diabetes Type 2 Patients
App 20130040878 - SILVESTRE; Louise ; et al. | 2013-02-14 |
Pharmaceutical Combination For Use In Inducing Weight Loss In Diabetes Type 2 Patients Or/and For Preventing Weight Gain In Diabetes Type 2 Patients
App 20130023467 - SILVESTRE; Louise ; et al. | 2013-01-24 |
Pharmaceutical Combination For Improving Glycemic Control As Add-on Therapy To Basal Insulin
App 20130005649 - NIEMOELLER; Elisabeth ; et al. | 2013-01-03 |
Prevention Of Hypoglycaemia In Diabetes Mellitus Type 2 Patients
App 20120277147 - BOKA; Gabor ; et al. | 2012-11-01 |
Use Of Idrabiotaparinux For Decreasing The Incidence Of Bleedings During An Antithrombotic Treatment
App 20110245200 - Cariou; Roger ; et al. | 2011-10-06 |
Method Of Treatment Of Diabetes Type 2 Comprising Add-on Therapy To Metformin
App 20110118180 - SILVESTRE; Louise ; et al. | 2011-05-19 |
Method Of Treatment Of Diabetes Type 2 Comprising Add-on Therapy To Insulin Glargine And Metformin
App 20110118178 - SILVESTRE; Louise ; et al. | 2011-05-19 |
| 